financetom
Business
financetom
/
Business
/
Wood Group conditionally accepts Sidara's takeover bid after a year-long pursuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wood Group conditionally accepts Sidara's takeover bid after a year-long pursuit
Aug 29, 2025 7:15 AM

(Reuters) -Wood Group has conditionally agreed to a takeover bid from Dubai-based Sidara, the companies said on Friday, ending a pursuit that spanned more than a year and involved multiple offers and rejections.

The 30-pence-per-share offer, which would value the British oilfield services company at 207.6 million pounds ($280.45 million), is subject to completion of certain exceptional conditions and includes a $450 million cash injection from Sidara.

The embattled Wood Group said its current liquidity was insufficient to fund operations and that it plans to pursue further cost-cutting measures through 2025.

"The current capital structure of the Wood Group is unsustainable," its board said in a statement.

Earlier this week, Sidara lowered its proposal for Wood Group after the Financial Conduct Authority launched a probe into British company's operations.

($1 = 0.7402 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MedImpact Expands Portfolio of Health Solutions with Acquisition of Two Employer Insurance and Risk Management Companies
MedImpact Expands Portfolio of Health Solutions with Acquisition of Two Employer Insurance and Risk Management Companies
Mar 12, 2026
SRS Benefit Partners and MSL Captive Solutions provide alternative risk financing solutions that protect employers from sky-high administrative fees and renewals SAN DIEGO--(BUSINESS WIRE)-- MedImpact Holdings, Inc., the nation’s largest independent health solutions and pharmacy benefit company, today announced the acquisition of two innovative risk management firms: MHW Benefit Partners (formerly SRS Benefit Partners) and MSL Captive Solutions. These...
Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets
Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets
Mar 12, 2026
Newly combined company will focus on delivering technology-enabled client service and next-generation infrastructure to support the growth of private markets firms NEW YORK & DUBLIN--(BUSINESS WIRE)-- Alchelyst and Lyra Client Solutions today announced the completion of their merger. The combined company, backed by Motive Partners and anchor client Apollo , is focused on supporting the continued evolution of private...
Motorola Solutions Acquires Exacom, a Leading Provider of Cloud-Native Recording and Logging Solutions for Mission-Critical 911 and Radio Communications
Motorola Solutions Acquires Exacom, a Leading Provider of Cloud-Native Recording and Logging Solutions for Mission-Critical 911 and Radio Communications
Mar 12, 2026
CHICAGO--(BUSINESS WIRE)-- Motorola Solutions ( MSI ) today announced it has acquired Exacom, a leading provider of cloud-native voice and multimedia recording and logging solutions for mission-critical communications, based in Manchester, New Hampshire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311755689/en/ Exacom’s solutions help public safety agencies consolidate call logs and record 911 audio and radio traffic...
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Mar 12, 2026
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors PARIS & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. ( KZR ) , a clinical-stage biotechnology company developing novel small...
Copyright 2023-2026 - www.financetom.com All Rights Reserved